COVID-19 · COVID-19 Vaccine

The Johnson & Johnson COVID-19 Vaccine Resumes

FDA and CDC Resumes the Johnson & Johnson COVID-19 Vaccine – FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review. #COVID19Vaccine #JohnsonJohnson

COVID-19 · COVID-19 Vaccine

Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine

Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine – As of April 12, 2021, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine.